ACHIEVEMENT OF LONG-TERM TREATMENT GOALS WITH UPADACITINIB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: A POST-HOC ANALYSIS OF INDUCTION AND MAINTENANCE PHASE 3 TRIALS

Julian Panés  1     Remo Panaccione  2     Marla C. Dubinsky  3     Yoh Ishiguro  4     Jacinda Tran  5, 6     Dapo Ilo     Jason Eccleston     Yuri Sanchez Gonzalez     Brian G. Feagan  7    
1 Hospital Clinic Barcelona, Barcelona, Spain
2 University of Calgary, Calgary, Canada
3 Icahn School of Medicine, Mount Sinai, New York City, United States
4 National Hirosaki Hospital, Hirosaki, Japan
5 University of Washington, Seattle, United States
6 AbbVie, Inc, North Chicago, United States
7 The University of Western Ontario, London, Canada

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing